Rong Mao, MD

Languages Spoken: Chinese, English

Dr. Mao is the Section Chief in the molecular genetics section at ARUP and Co-Program Director for the clinical molecular genetics fellowship training program. Previously, Dr. Mao served as the assistant laboratory director of the DNA Diagnostic Laboratory at the University of Utah Health Sciences Center and as a consultant for the Molecular Genetics Laboratory at the Mayo Clinic. As a clinical specialist, Dr. Mao helped establish the molecular diagnostics section of genetics at Rush Presbyterian - St. Luke's Medical Center in Chicago. Dr. Mao is certified by the American Board of Medical Genetics with a subspecialty in clinical molecular genetics, and the New York State Department of Health with a subspecialty in genetic testing.

Dr. Mao has focused her research efforts on: Disease associated genes/genes for congenital hearing loss; Mutation scanning methods; Genetic imprint defects and methylation associated diseases; Alpha-1- antitrypsin (AAT) deficiency, genotype-phenotype correlation; and Mutation detection for Metabolic disorders.

Dr. Mao is the Section Chief in the molecular genetics section at ARUP and Co-Program Director for the clinical molecular genetics fellowship training program. Previously, Dr. Mao served as the Assistant Laboratory Director of the DNA Diagnostic Laboratory at the University of Utah Health Sciences Center and as a consultant for the Molecular Genetics Laboratory at the Mayo Clinic. As a clinical specialist, Dr. Mao helped establish the molecular diagnostics section of genetics at Rush Presbyterian - St. Luke's Medical Center in Chicago. Dr. Mao is certified by the American Board of Medical Genetics with a subspecialty in clinical molecular genetics, and the New York State Department of Health with a subspecialty in genetic testing.

Dr. Mao has focused her research efforts on: Disease associated genes/genes for congenital hearing loss; Mutation scanning methods; Genetic imprint defects and methylation associated diseases; Alpha-1- antitrypsin (AAT) deficiency, genotype-phenotype correlation; and Mutation detection for Metabolic disorders.

Dr. Mao is the Section Chief in the molecular genetics section at ARUP and Co-Program Director for the clinical molecular genetics fellowship training program. Previously, Dr. Mao served as the assistant laboratory director of the DNA Diagnostic Laboratory at the University of Utah Health Sciences Center and as a consultant for the Molecular Genetics Laboratory at the Mayo Clinic. As a clinical specialist, Dr. Mao helped establish the molecular diagnostics section of genetics at Rush Presbyterian - St. Luke's Medical Center in Chicago. Dr. Mao is certified by the American Board of Medical Genetics with a subspecialty in clinical molecular genetics, and the New York State Department of Health with a subspecialty in genetic testing.

Dr. Mao has focused her research efforts on: Disease associated genes/genes for congenital hearing loss; Mutation scanning methods; Genetic imprint defects and methylation associated diseases; Alpha-1- antitrypsin (AAT) deficiency, genotype-phenotype correlation; and Mutation detection for Metabolic disorders.

Dr. Mao is the Section Chief in the molecular genetics section at ARUP and Co-Program Director for the clinical molecular genetics fellowship training program. Previously, Dr. Mao served as the Assistant Laboratory Director of the DNA Diagnostic Laboratory at the University of Utah Health Sciences Center and as a consultant for the Molecular Genetics Laboratory at the Mayo Clinic. As a clinical specialist, Dr. Mao helped establish the molecular diagnostics section of genetics at Rush Presbyterian - St. Luke's Medical Center in Chicago. Dr. Mao is certified by the American Board of Medical Genetics with a subspecialty in clinical molecular genetics, and the New York State Department of Health with a subspecialty in genetic testing.

Dr. Mao has focused her research efforts on: Disease associated genes/genes for congenital hearing loss; Mutation scanning methods; Genetic imprint defects and methylation associated diseases; Alpha-1- antitrypsin (AAT) deficiency, genotype-phenotype correlation; and Mutation detection for Metabolic disorders.